久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / The Second China International Import Expo

Pharma firms use expo to boost collaboration

By Zhou Wenting in Shanghai | China Daily | Updated: 2019-11-08 10:47
Share
Share - WeChat
Visitors check out a surgery robot during the second CIIE in Shanghai on Thursday. [Photo by Feng Yongbin/China Daily]

Riding the wave of the country's shift from basic healthcare to innovative healthcare, global pharmaceutical businesses are using the platform of the ongoing China International Import Expo to upgrade collaboration with local governments to better serve the country's Healthy China 2030 Initiative.

Besides showcasing their most advanced innovative therapies - ranging from oncology and rare disease medication to personalized healthcare solutions - many enterprises are reaching new agreements with governments by bringing their latest therapies and technologies to meet patients' needs in the country, currently the world's second-largest pharmaceuticals market.

China's healthcare market is expected to reach 8 trillion yuan ($1.14 trillion) by 2020 and double the figure by 2030, according to the Healthy China 2030 blueprint.

Switzerland-based Roche signed a strategic collaboration with the Boao Lecheng International Medical Tourism Pilot Zone in Hainan province during the CIIE on Wednesday to introduce a series of innovative drugs, including the first novel proposed mechanism to treat influenza approved by the United States Food and Drug Administration in nearly two decades, in the zone.

"Roche always puts patients first and spares no effort to develop innovative drugs and allow patients to have access to them as early as possible. We hope to collaborate with the country's pilot policies and mechanisms, including such a medical tourism pilot zone, to allow some patients to access the new therapies - lifesavers in many cases - in advance," said Hong Chow, CEO of Roche Pharmaceuticals China.

The company also said that it anticipates one of its CIIE blockbuster exhibition products - an immunotherapy that successfully completed phase III global clinical trials in hepatic cellular cancer in late October and for which the company is making a new drug application in the United States, Europe and China simultaneously - to make its world debut in China.

"We hope that the new drug will be launched in China as half of the worldwide 750,000 HCC patients every year are in China, and most of them are in the late-stages when diagnosed and they survive an average of less than a year after diagnosis," Chow said.

AstraZeneca announced its plan to play up Shanghai as the British-Swedish pharmaceutical multinational's global research and development base to ultimately better serve unmet medical needs of patients in China and the outside world, and establish an artificial intelligence-powered China innovation center in the city during the expo on Wednesday, part of its upgraded strategic cooperation with the Shanghai municipal government.

The upgraded global R&D center will strengthen China's role in Astra-Zeneca's worldwide network for new drug R&D, promoting the incubation of more global and local new drugs in China for the world, and the AI innovation center will utilize the latest technologies to empower new healthcare services throughout the whole process from R&D, manufacturing, and operation to commercialization, the company said.

"As China rapidly emerges as a global scientific powerhouse and China's position in our global R&D network continuously improves, we aim to develop more local and global innovative drugs in China, and Shanghai is home to an increasing number of high-tech industries," said Pascal Soriot, chief executive officer of AstraZeneca.

Tapping into the potential of intelligent medical industry, the company announced to jointly build the Wuxi International Life Science Innovation Campus together with Wuxi city government and Wuxi high-tech zone in Jiangsu province, in September, and during the CIIE the company reached multiple agreements with cross-border partners, including enterprises from India and the United Kingdom, which it worked with in the campus to build an incubation platform for early R&D and the industrialization of research achievements.

Also on Wednesday, US-based pharmaceutical company Pfizer signed three cooperation agreements, including those with the China Alliance of Rare Diseases and Microsoft Research, an institute specializing in basic and applied research, aiming to elevate the country's disease diagnosis and treatment standards in various disease areas.

"The collaboration with CARD is aimed at standardizing the medical treatment that rare disease patients can access in different regions and a better accessibility of drugs to ultimately improve their quality of life," said Wu Kun, Pfizer China Biopharma country lead.

The cooperation with the institute will produce an AI-powered system to elevate the diagnosis and treatment levels of infectious diseases and promote the reasonable use of antibacterial agents, he explained.

In October, the National Health Commission announced that the five-year survival rate among cancer patients had risen from 30.9 percent to 40.5 percent over the past decade.

Several multinational pharmaceutical enterprises said that they had benefitted from the country's streamlined innovative drug approval procedure and better drug accessibility by promoting more medicines to be included in the National Reimbursement Drug List in the past years, and they were proud to have contributed to that improvement.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    日韩一级免费在线观看| 成人在线免费观看网址| 成人高清在线观看视频| 和岳每晚弄的高潮嗷嗷叫视频| 国产精品人人爽人人爽| 国产一区 在线播放| 性欧美1819| 国产精品12345| 欧美在线a视频| 欧美在线观看视频网站| 青青青青在线视频| gai在线观看免费高清| 99热在线这里只有精品| 特级西西444| 九九九九九九九九| 日韩无套无码精品| 男女啪啪免费视频网站| 最新av在线免费观看| 九色91popny| 免费无码av片在线观看| 国产一区二区三区播放| 国产成人美女视频| 久久精品免费网站| 日韩在线综合网| 日本a级片在线播放| 日韩精品视频网址| 911福利视频| 蜜臀av免费观看| 已婚少妇美妙人妻系列| 欧美 日韩 国产在线观看| 青草网在线观看| 午夜久久久久久久久久久| 97人人爽人人| 色播五月综合网| 亚洲少妇久久久| 爱情岛论坛成人| 欧美 激情 在线| 91视频 -- 69xx| 免费毛片网站在线观看| 黄色三级中文字幕| 日本一级黄视频| 黄色一级片黄色| 毛片av免费在线观看| 欧美黑人经典片免费观看| 成人网站免费观看入口| 日本手机在线视频| 黄色大片中文字幕| 欧美日韩二三区| 妺妺窝人体色www在线小说| 欧美 国产 综合| 久久免费视频3| 日日碰狠狠躁久久躁婷婷| 农村妇女精品一二区| 日韩av在线综合| 国产小视频精品| 天堂网在线免费观看| 亚洲美女性囗交| 国产精品探花在线播放| 中文字幕av久久| av在线com| 免费在线观看亚洲视频| 免费午夜视频在线观看| 国产三级三级看三级| 亚洲黄色av片| 桥本有菜av在线| 久久99久久99精品| 波多野结衣综合网| 国产成人手机视频| 亚洲一区精品视频在线观看| 波多野结衣激情| 韩日视频在线观看| 六月丁香婷婷激情| 香蕉视频禁止18| 免费成人进口网站| 国产精品igao激情视频| 日韩视频免费播放| 不卡av免费在线| 午夜激情视频网| 成人免费性视频| 欧美女人性生活视频| 性生生活大片免费看视频| 看全色黄大色大片| 欧美女人性生活视频| 天天操天天干天天做| 奇米777四色影视在线看| 激情五月开心婷婷| 日韩a一级欧美一级| 男人的天堂狠狠干| 欧美特黄aaa| www在线观看免费| 日韩一区二区三区久久| 波多野结衣与黑人| 女人另类性混交zo| 久久精品一二三四| 日本三级免费网站| 红桃视频一区二区三区免费| 日本一区午夜艳熟免费| 午夜宅男在线视频| 国产欧美日韩小视频| 美女网站视频黄色| 久操手机在线视频| www.涩涩涩| 成人在线播放网址| 凹凸国产熟女精品视频| 亚洲18在线看污www麻豆| 国产二区视频在线| 国产一区二区在线观看免费视频| 一二三四视频社区在线| 日韩欧美理论片| 日本在线视频www| 99久久99久久精品| 鲁一鲁一鲁一鲁一av| 婷婷五月综合缴情在线视频| 欧美午夜精品理论片| 成年人视频网站免费观看| 超碰10000| 99久久99精品| wwwwxxxx日韩| www.中文字幕在线| 日韩国产小视频| 欧美 日韩 国产 在线观看| 久久久精品三级| 噜噜噜久久亚洲精品国产品麻豆| 在线观看av的网址| 中文字幕55页| 天天干天天av| 天堂社区在线视频| 无码人妻精品一区二区三区在线 | 亚洲 欧美 日韩 国产综合 在线| 国产精品久久久久久久99| 国产免费视频传媒| 欧美二区在线视频| 欧美激情亚洲天堂| 999热精品视频| 欧美国产日韩激情| 日韩精品一区二区三区电影| 女性隐私黄www网站视频| 国产永久免费网站| 亚洲一区精品视频在线观看| 91好吊色国产欧美日韩在线| 在线播放黄色av| 日本在线观看免费视频| 国产黄色特级片| 成人午夜视频在线观看免费| 亚洲综合20p| 男女视频在线看| 三上悠亚av一区二区三区| 久久精品免费一区二区| 日韩免费在线观看av| 久久精品亚洲天堂| 奇米777在线视频| 手机在线免费观看毛片| 熟女性饥渴一区二区三区| 国产乱子伦精品无码专区| 国产va亚洲va在线va| 国产欧美综合一区| 国产不卡的av| 高潮一区二区三区| 网站在线你懂的| www.亚洲高清| 97公开免费视频| aa免费在线观看| 日本在线观看免费视频| 黑鬼大战白妞高潮喷白浆| 欧美三级在线观看视频| 亚洲国产精品无码观看久久| 懂色av粉嫩av蜜臀av| 欧美一级免费在线观看| 日本特黄在线观看| 日本精品一区在线| 国产精品丝袜久久久久久消防器材 | 一级特黄妇女高潮| 四虎成人在线播放| 亚洲色婷婷久久精品av蜜桃| 超碰97免费观看| 91香蕉视频免费看| 超碰免费在线公开| 欧美一区二区激情| 搞av.com| 国产女大学生av| 中文字幕第80页| 在线免费观看视频黄| www.亚洲高清| 91pony九色| 国产精品国三级国产av| 岛国大片在线播放| 欧美三级在线观看视频| 国产aaa免费视频| 欧美成人黑人猛交| wwwwww.色| 久久久久久久久久毛片| 看一级黄色录像| 成人免费毛片在线观看| 国产最新免费视频| 污片在线免费看| 91国在线高清视频| 成人综合视频在线| 爱情岛论坛成人| 男人c女人视频| 国产在线观看福利|